Targeting JAK3 Tyrosine Kinase-Linked Signal Transduction Pathways with Rationally-Designed Inhibitors

E-ISSN： 1875-5992|7|6|612-623

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.7, Iss.6, 2007-11, pp. : 612-623

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 6, 2011-07 ,pp. : 560-575

Bentham Science Publishers

Access to resources Recommend Favorite

Screening of kinase inhibitors targeting BRAF for regulating autophagy based on kinase pathways

Molecular Medicine Reports, Vol. 9, Iss. 1, 2014-01 ,pp. : 83-90

Spandidos Publications

Access to resources Recommend Favorite

Signal Transduction Inhibitors

By Grunicke H.

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 833-834

Elsevier

Access to resources Recommend Favorite

Signal Transduction Inhibitors as Radiosensitizers

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 6, 2002-11 ,pp. : 727-742

Bentham Science Publishers

Access to resources Recommend Favorite

Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells

By Scholl Sebastian Kirsch Cornelia Böhmer Frank Klinger Reinhard

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 12, 2004-12 ,pp. : 711-718

Springer Publishing Company

Access to resources Recommend Favorite